Skip to main content
SpringerLink
Log in

Pediatric Maxillofacial Conditions and Drugs

  • Chapter
  • First Online:
Bone Drugs in Pediatrics

  • 744 Accesses

Abstract

Systemic and local conditions involving the craniofacial skeleton are uncommon. Given similarities between pathologic entities, diagnosis and treatment can be challenging. Surgical and/or pharmacologic management during skeletal growth affects treatment decisions. In this chapter, we will discuss several maxillofacial bony conditions, their presentation, and management. We will also discuss therapeutic options with associated risks and benefits.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kaban LB, Dodson TB. Management of giant cell lesions. Int J Oral Maxillofac Surg. 2006;35(11):1074–5.

    Article  PubMed  CAS  Google Scholar 

  2. Papadaki ME, Troulis MJ, Kaban LB. Advances in diagnosis and management of fibro-osseous lesions. Oral Maxillofac Surg Clin North Am. 2005;17(4):415–34.

    Article  PubMed  Google Scholar 

  3. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg. 1986;44(9):708–13.

    Article  PubMed  CAS  Google Scholar 

  4. Neville BW, Damm DD, Allen CM, Bouquot JE. Giant cell lesions. In: Oral and maxillofacial pathology, Neville, Damm, Allen, Bouquot editors. New York: WB Saunders; 2004, pp. 611–620.

    Google Scholar 

  5. Susarla SM, August M, Dewsnup N, Faquin WC, Kaban LB, Dodson TB. CD34 staining density predicts giant cell tumor clinical behavior. J Oral Maxillofac Surg. 2009;67(5):951–6.

    Article  PubMed  Google Scholar 

  6. Dewsnup NC, Susarla SM, Abulikemu M, Faquin WC, Kaban LB, August M. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis. J Oral Maxillofac Surg. 2008;66(5):928–33.

    Article  PubMed  Google Scholar 

  7. Kaban LB, Mulliken JB, Ezekowitz RA, Ebb D, Smith PS, Folkman J. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics. 1999;103(6 Pt 1):1145–9.

    Article  PubMed  CAS  Google Scholar 

  8. Chuong R, Kaban LB. Diagnosis and treatment of jaw tumors in children. J Oral Maxillofac Surg. 1985;43(5):323–32.

    Article  PubMed  CAS  Google Scholar 

  9. Kaban LB, Troulis MJ, Wilkinson MS, Ebb D, Dodson TB. Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg. 2007;65(10):2018–24.

    Article  PubMed  Google Scholar 

  10. Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ. Cherubism: best clinical practice. Orphanet J Rare Dis. 2012;7 Suppl 1:S6.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Jones WA. Familial multilocular cystic disease of the jaws. Am J Cancer. 1933;17:946–50.

    Article  Google Scholar 

  12. Jones WA. Further observations regarding familial multilocular cystic disease of the jaws. Br J Radiol. 1938;11:227–41.

    Article  Google Scholar 

  13. Von Wowern N. Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(6):765–72.

    Article  Google Scholar 

  14. Chacon GE, Ugalde CM, Jabero MF. Genetic disorders and bone affecting the craniofacial skeleton. Oral Maxillofac Surg Clin North Am. 2007;19(4):467–74, v.

    Article  PubMed  Google Scholar 

  15. Thompson N. Cherubism: familial fibrous dysplasia of the jaws. Br J Plast Surg. 1959;12:89–103.

    Article  Google Scholar 

  16. McClendon JL, Anderson DE, Cornelius EA. Cherubism—hereditary fibrous dysplasia of the jaws: II. Pathologic considerations. Oral Surg Oral Med Oral Pathol. 1962;15(Suppl):17–38.

    Google Scholar 

  17. Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, Ninomiya C. doAmaral C, Peters H, Habal M, Rhee-Morris L, Doss JB, Kreiborg S, Olsen BR, Reichenberger E. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28(2):125–6.

    Article  PubMed  CAS  Google Scholar 

  18. Tiziani V, Reichenberger E, Buzzo CL, Niazi S, Fukai N, Stiller M, Peters H, Salzano FM, Raposo doAmaral CM, Olsen BR. The gene for cherubism maps to chromosome 4p16. Am J Hum Genet. 1999;65(1):158–66.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Noonan J, Ehmke D. Associated noncardiac malformations in children with congenital heart disease. J Pediatr. 1963;63:468–70.

    Google Scholar 

  20. Lee SM, Cooper JC. Noonan syndrome with giant cell lesions. Int J Paediatr Dent. 2005;15(2):140–5.

    Article  PubMed  CAS  Google Scholar 

  21. Cohen Jr MM, Gorlin RJ. Review Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet. 1991;40(2):159–66.

    Article  PubMed  Google Scholar 

  22. Tartaglia M, Zampino G, Gelb BD. Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol. 2010;1(1):2–26.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Lee JS, Tartaglia M, Gelb BD, Fridrich K, Sachs S, Stratakis CA, Muenke M, Robey PG, Collins MT, Slavotinek A. Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. J Med Genet. 2005;42(2):e11.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Jafarov T, Ferimazova N, Reichenberger E. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Clin Genet. 2005;68(2):190–1.

    Article  PubMed  CAS  Google Scholar 

  25. Beneteau C, Cavé H, Moncla A, Dorison N, Munnich A, Verloes A, Leheup B. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions. Eur J Hum Genet. 2009;17(10):1216–21.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Edwards PC, et al. Bilateral central giant cell granulomas of the mandible in an 8-year-old girl with Noonan syndrome (Noonan-like/multiple giant cell lesion syndrome). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(3):334–40.

    Article  PubMed  Google Scholar 

  27. Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis. 2012;24(7 Suppl 1):S2.

    Article  Google Scholar 

  28. Chen YR, Wong FH, Hsueh C, Lo LJ. Computed tomography characteristics of non-syndromic craniofacial fibrous dysplasia. Chang Gung Med J. 2002;25(1):1–8.

    PubMed  Google Scholar 

  29. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A. 1992;89(11):5152–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.

    Article  PubMed  CAS  Google Scholar 

  31. Park BY, Cheon YW, Kim YO, Pae NS, Lee WJ. Prognosis for craniofacial fibrous dysplasia after incomplete resection: age and serum alkaline phosphatase. Int J Oral Maxillofac Surg. 2010;39:221.

    Article  PubMed  CAS  Google Scholar 

  32. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412.

    Article  PubMed  CAS  Google Scholar 

  33. Cohen Jr MM. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Genet. 2002;108:265–74.

    Article  PubMed  Google Scholar 

  34. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37(8):520–76.

    Article  Google Scholar 

  35. Kaban LB, Mulliken JB. Maxillofacial vascular anomalies. In: Pediatric oral and maxillofacial surgery. Kaban LB, Troulis MJ, editors. Philadelphia: WB Saunders; 2004, pp. 259–285.

    Google Scholar 

  36. Kaban LB, Mulliken JB. Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg. 1986;44:203.

    Article  PubMed  CAS  Google Scholar 

  37. Finn MC, Mulliken JB, Glowacki J. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894.

    Article  PubMed  CAS  Google Scholar 

  38. Abramowicz S, Padwa BL. Vascular anomalies in children. Oral Maxillofac Surg Clin North Am. 2012;24(3):443–55.

    Article  PubMed  Google Scholar 

  39. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg. 1998;102:643–54.

    Article  PubMed  CAS  Google Scholar 

  40. Steiner, RD; Pepin, MG, Byers, PH, Pagon, RA, Bird, TD, Dolan, CR, Stephens, K, Adam, MP (2005). Osteogenesis Imperfecta. PMID 20301472. http://www.ncbi.nlm.nih.gov/books/NBK1295. Retrieved Nov 28, 2012.

  41. Rosén A, Modig M, Larson O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Maxillofac Surg. 2011;40(8):866–73.

    Article  PubMed  Google Scholar 

  42. Tashima H, Wattanawong K, Ho CT, Wen-Ching-Ko E, Nguyen A, Lo LJ. Orthognathic surgery considerations for patients with undiagnosed type I osteogenesis imperfecta. J Oral Maxillofac Surg. 2011;69(8):2233–41.

    Article  PubMed  Google Scholar 

  43. López-Arcas JM, Chamorro M, Del Castillo JL, Cebrián JL, Palacios E, Burgueño M. Osteogenesis imperfecta and orthognathic surgery: case report and literature review. J Oral Maxillofac Surg. 2009;67(5):1128–32.

    Article  PubMed  Google Scholar 

  44. Turer CB, Lin H, Flores G. Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics. 2013;131(1):e152–61.

    Article  PubMed  Google Scholar 

  45. Wacker M, Holick MF. Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5(1):111–48.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  46. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8. PMCID: 3046611.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  47. Rizzoli R, Boonen S, Brandi ML, Bruyere O, Cooper C, Kanis JA, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013;29:305–13.

    Article  PubMed  CAS  Google Scholar 

  48. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2012;24(2):567–80.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Vanstone MB, Oberfield SE, Shader L, Ardeshirpour L, Carpenter TO. Hypercalcemia in children receiving pharmacologic doses of vitamin D. Pediatrics. 2012;129(4):e1060–3.

    Article  PubMed  Google Scholar 

  50. Winzenberg T, Shaw K, Fryer J, Jones G. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ. 2006;333(7572):775. PMCID: 1602024.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  51. Zhu K, Prince RL. Calcium and bone. Clin Biochem. 2012;45(12):936–42.

    Article  PubMed  CAS  Google Scholar 

  52. Candelas G, Martinez-Lopez JA, Rosario MP, Carmona L. Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review. Clin Exp Rheumatol. 2012;30(6):954–61.

    PubMed  Google Scholar 

  53. Spence LA, Weaver CM. Calcium intake, vascular calcification, and vascular disease. Nutr Rev. 2013;71:115–22.

    Article  Google Scholar 

  54. Falk MJ, Heeger S, Lynch KA, DeCaro KR, Bohach D, Gibson KS, et al. Intravenous bisphosphonate therapy in children with osteogenesis imperfecta. Pediatrics. 2003;111(3):573–8.

    Article  PubMed  Google Scholar 

  55. Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002;110(9):1293–9. PMCID: 151613.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  56. Ward LM, Rauch F, Whyte MP, D’Astous J, Gates PE, Grogan D, et al. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab. 2011;96(2):355–64.

    Article  PubMed  CAS  Google Scholar 

  57. Sellmeyer DE. Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA. 2010;304(13):1480–4.

    Article  PubMed  CAS  Google Scholar 

  58. Leet AI, Collins MT. Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop. 2007;11:3–17. PMCID: 2656698.

    Article  Google Scholar 

  59. Liamis G, Milionis HJ, Elisaf M. A review of drug-induced hypocalcemia. J Bone Miner Metab. 2009;27(6):635–42.

    Article  PubMed  CAS  Google Scholar 

  60. Amanata N, He LH, Swain MV, Little DG. The effect of zoledronic acid on the intrinsic material properties of healing bone: an indentation study. Med Eng Phys. 2008;30:7843–7.

    Google Scholar 

  61. Kim TY, Ha YC, Kang BJ, Lee YK, Koo KH. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg Br. 2012;94(7):956–60.

    Article  PubMed  Google Scholar 

  62. Kidd LJ, Cowling NR, Wu AC, Kelly WL, Forwood MR. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. J Orthop Res. 2011;29(12):1827–33.

    Article  PubMed  CAS  Google Scholar 

  63. Sharma D, Ivanovski S, Slevin M, Hamlet S, Pop TS, Brinzaniuc K, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vasc Cell. 2013;5(1):1.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Maines E, Monti E, Doro F, Morandi G, Cavarzere P, Antoniazzi F. Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. J Bone Miner Metab. 2012;30(4):434–8.

    Article  PubMed  CAS  Google Scholar 

  65. Malmgren B, Astrom E, Soderhall S. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med. 2008;37(4):196–200.

    Article  PubMed  CAS  Google Scholar 

  66. Schwartz S, Joseph C, Iera D, Vu DD. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. J Can Dent Assoc. 2008;74(6):537–42.

    PubMed  Google Scholar 

  67. Report of the Council of Scientific Affairs. Expert panel recommendations: dental management of patients on oral bisphosphonate therapy. American Dental Association, June 2006. http://www.ada.org/prof/resources/topics/osteonecrosis.asp. Accessed Jan 11, 2013.

  68. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg. 2009;67(5 Suppl):2–12.

    PubMed  Google Scholar 

  69. Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A. Denosumab for post-transplantation hypercalcemia in osteopetrosis. N Engl J Med. 2012;367(18):1766–7.

    Article  PubMed  CAS  Google Scholar 

  70. Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, et al. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012;27(7):1462–70.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  71. Watanabe A, Yoneyama S, Nakajima M, Sato N, Takao-Kawabata R, Isogai Y, et al. Osteosarcoma in Sprague–Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1–34)). J Toxicol Sci. 2012;37(3):617–29.

    Article  PubMed  CAS  Google Scholar 

  72. Mason JJ, Williams BO. SOST and DKK: antagonists of LRP family signaling as targets for treating bone disease. J Osteoporos. 2010;2010:460120. PMCID: 2951123.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Plastic and Reconstructive Surgery, Johns Hopkins Hospital, 801 N. Caroline Street, Baltimore, MD, 21285, USA

    Srinivas M. Susarla D.M.D., M.D., M.P.H.

  2. Divisions of Endocrinology and Clinical Genetics, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA

    Christina M. Jacobsen M.D., Ph.D.

  3. Department of Surgery, Division of Oral and Maxillofacial Surgery, Emory University School of Medicine, Building B, Suite 2300, 1365 Clifton Road, NE, Atlanta, GA, 30322, USA

    Shelly Abramowicz D.M.D., M.P.H.

Authors
  1. Srinivas M. Susarla D.M.D., M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina M. Jacobsen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shelly Abramowicz D.M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shelly Abramowicz D.M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. Department of Orthopaedic Surgery, University of Texas Medical Branch, Galveston, Texas, USA

    Gordon L. Klein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Susarla, S.M., Jacobsen, C.M., Abramowicz, S. (2014). Pediatric Maxillofacial Conditions and Drugs. In: Klein, G. (eds) Bone Drugs in Pediatrics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7436-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7436-5_11

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7435-8

  • Online ISBN: 978-1-4899-7436-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation